Louisiana State Employees Retirement System purchased a new position in shares of Humana Inc. (NYSE:HUM – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 6,100 shares of the insurance provider’s stock, valued at approximately $1,058,000.
Other hedge funds have also made changes to their positions in the company. Montag A & Associates Inc. boosted its holdings in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC increased its stake in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new stake in Humana during the fourth quarter worth approximately $27,000. Reflection Asset Management purchased a new stake in shares of Humana during the 4th quarter worth approximately $29,000. Finally, Rosenberg Matthew Hamilton lifted its position in shares of Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Analyst Ratings Changes
Several brokerages recently commented on HUM. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Humana in a research note on Monday, June 1st. Morgan Stanley upped their price objective on shares of Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a research note on Thursday, June 4th. Robert W. Baird dropped their price objective on Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 29th. Finally, Bank of America boosted their target price on Humana from $340.00 to $380.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $293.09.
Humana Stock Down 0.1%
HUM opened at $396.38 on Friday. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $415.00. The business has a 50 day moving average price of $321.87 and a two-hundred day moving average price of $250.56. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The company has a market cap of $47.59 billion, a PE ratio of 42.39, a P/E/G ratio of 2.26 and a beta of 0.71.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue was up 23.5% on a year-over-year basis. During the same period last year, the business posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts anticipate that Humana Inc. will post 9.03 EPS for the current year.
Humana Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is 37.86%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil JalapeƱo: An Early Step to Massive AI Growth Potential
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
